TREM2 and bladder transitional cell carcinoma: In bladder cancer (BLCA), TREM2 expression is also associated with tumor progression and decreased immunotherapy efficacy, and TREM2 may play a role by promoting epithelial mesenchymal transition (EMT) and T-cell exhaustion (35).